Breast Cancer Risk via Cell Squeezing Technology
Key Highlights Novel cell-squeezing technology assesses breast cancer risk at the cellular level. Microfluidic platform measures cell deformation and recovery
Read MoreKey Highlights Novel cell-squeezing technology assesses breast cancer risk at the cellular level. Microfluidic platform measures cell deformation and recovery
Read MoreAccording to a new meta-analysis co-directed by Johns Hopkins Kimmel Cancer Center investigators, soy compounds known as isoflavones are among
Read MoreAccording to a new study by Ramya Ganesan of Emory University in the US and colleagues, a typical chemotherapy treatment
Read MoreThe survival rate for breast cancer in its initial stages is almost 100%. However, that incidence lowers to about 25%
Read MoreAccording to a new study published in Nature Communications, researchers from Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Medical
Read MoreBreast Cancer screening with mammograms is done by many middle-aged and older women, every one to two years, as suggested
Read MoreDigital breast tomosynthesis (DBT) demonstrated improved breast cancer screening outcomes compared to screening with traditional digital mammography alone in a
Read MoreResearchers now understand why lung-resident breast cancer cells can “wake up” after years of dormancy to create inoperable secondary breast
Read More